The depressant effects send us to sleep, but we skip the most important part the restorative REM stages
Yoshii Y, Furukawa T, Waki A, Okuyama H, Inoue M, Itoh M, et al
With Blood-Based Test Approval, Alzheimers Biomarker Testing Has Grown 37.5x, and Dementia Diagnosing Has Shifted Toward Earlier, Milder Stages July 30, 2026 With Blood-Based Test Approval, Alzheimers Biomarker Testing Has Grown 37.5x, and Dementia Diagnosing Has Shifted Toward Earlier, Milder Stages Biomarker tests for Alzheimers increased 37.5x between 2023 and 2025, diagnoses trended milder, but specialist shortages may leave the health system unprepared for surging dementia care demand
Common side effects of the drug include nausea, vomiting, diarrhea, constipation and indigestion